Given the critical role of the tumor microenvironment in modulating immune responses (26), ASCL1’s association with various immunomodulatory factors—including cytokines, immunomodulators, MHC molecules, and receptors—was assessed across multiple cancers, including BC. The gene discussed is HLA-C; the disease is neoplasm.